Oculis Holding AG (OCS) Interest Expenses (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Interest Expenses came in at -$42141.2 in Q1 2026, down 215.73% year-on-year from $36411.8 in Q1 2025, and up 6.44% quarter-over-quarter from -$45042.1 in Q4 2025.

Oculis Holding AG (OCS) Interest Expenses (2022 - 2026) Analysis & Trends

Oculis Holding AG's Interest Expenses history runs 5 years deep, the most recent figure standing at -$42141.2 for Q1 2026.

  • On a quarterly basis, Interest Expenses fell 215.73% year-over-year to -$42141.2 in Q1 2026; TTM through Mar 2026 was -$135473.1, a 114.05% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 38.32% from the prior year.
  • Interest Expenses rose to -$42141.2 in Q1 2026 per OCS's latest filing, from -$45042.1 in the prior quarter.
  • Across five years, Interest Expenses topped out at $6.7 million in Q4 2022 and bottomed at -$1.7 million in Q2 2022.
  • The 5-year median for Interest Expenses is -$15525.8 (2023), against an average of $291159.7.
  • Across the five-year window, Interest Expenses surged 5149.09% in 2023 and sank 215.73% in 2026, its largest moves.
  • Year by year, Interest Expenses stood at $6.7 million in 2022, then slumped by 122.17% to -$1.5 million in 2023, then surged by 99.0% to -$14839.8 in 2024, then tumbled by 203.52% to -$45042.1 in 2025, then climbed by 6.44% to -$42141.2 in 2026.
  • Per Business Quant, the three latest OCS Interest Expenses figures stand at -$42141.2 (Q1 2026), -$45042.1 (Q4 2025), and -$35003.1 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 69.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -42,141.15
Mar 31, 2026 -42,141.15
Dec 31, 2025 -45,042.11
Dec 31, 2025 -45,042.11
Sep 30, 2025 -35,003.07
Sep 30, 2025 -35,003.07
Jun 30, 2025 -13,286.79
Jun 30, 2025 -13,286.79
Mar 31, 2025 -13,347.01
Mar 31, 2025 -13,347.01
Dec 31, 2024 -14,839.78
Dec 31, 2024 -14,839.78
Sep 30, 2024 -19,621.52
Sep 30, 2024 -19,621.52
Jun 30, 2024 -15,481.11
Jun 30, 2024 -15,481.11
Mar 31, 2024 -11,456.82
Mar 31, 2024 -11,456.82
Dec 31, 2023 -1.48 Mn
Dec 31, 2023 -1.48 Mn